Literature DB >> 34029561

Mucociliary Clearance Differs in Mild Asthma by Levels of Type 2 Inflammation.

Timothy E Corcoran1, Alex S Huber2, Sherri L Hill3, Landon W Locke4, Lawrence Weber5, Ashok Muthukrishnan6, Elisa M Heidrich3, Sally Wenzel7, Mike M Myerburg3.   

Abstract

BACKGROUND: Although mucus plugging is a well-reported feature of asthma, whether asthma and type 2 inflammation affect mucociliary clearance (MCC) is unknown. RESEARCH QUESTION: Does type 2 inflammation influence mucus clearance rates in patients with mild asthma who are not receiving corticosteroids? STUDY DESIGN AND METHODS: The clearance rates of inhaled radiolabeled particles were compared between patients with mild asthma with low (n = 17) and high (n = 18) levels of T2 inflammation. Fraction exhaled nitric oxide (Feno) was used to prospectively segregate subjects into T2 Lo (Feno < 25 ppb) and T2 Hi (Feno > 35 ppb) cohorts. Bronchial brush samples were collected with fiber-optic bronchoscopy, and quantitative polymerase chain reaction was performed to measure expression of genes associated with T2 asthma. MCC rate comparisons were also made with a historical group of healthy control subjects (HCs, n = 12).
RESULTS: The T2 Lo cohort demonstrated increased MCC when compared with both T2 Hi and historic HCs. MCC within the T2 Hi group varied significantly, with some subjects having low or zero clearance. MCC decreased with increasing expression of several markers of T2 airway inflammation (CCL26, NOS2, and POSTN) and with Feno. MUC5AC and FOXJ1 expression was similar between the T2Lo and T2Hi cohorts.
INTERPRETATION: Increasing T2 inflammation was associated with decreasing MCC. High rates of MCC in T2 Lo subjects may indicate a compensatory mechanism present in mild disease but lost with high levels of inflammation. Future studies are required to better understand mechanisms and whether impairments in MCC in more severe asthma drive worse clinical outcomes.
Copyright © 2021 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  asthma; cilia; lung imaging; mucociliary clearance; mucus; scintigraphy; type 2 inflammation

Mesh:

Substances:

Year:  2021        PMID: 34029561      PMCID: PMC8628176          DOI: 10.1016/j.chest.2021.05.013

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  37 in total

1.  Mucociliary clearance in adult asthma.

Authors:  T G O'Riordan; J Zwang; G C Smaldone
Journal:  Am Rev Respir Dis       Date:  1992-09

2.  Pulmonary epithelial sodium-channel dysfunction and excess airway liquid in pseudohypoaldosteronism.

Authors:  E Kerem; T Bistritzer; A Hanukoglu; T Hofmann; Z Zhou; W Bennett; E MacLaughlin; P Barker; M Nash; L Quittell; R Boucher; M R Knowles
Journal:  N Engl J Med       Date:  1999-07-15       Impact factor: 91.245

3.  Comparison of two methods of collecting induced sputum in asthmatic subjects.

Authors:  N H Gershman; H H Wong; J T Liu; M J Mahlmeister; J V Fahy
Journal:  Eur Respir J       Date:  1996-12       Impact factor: 16.671

4.  Oxidation increases mucin polymer cross-links to stiffen airway mucus gels.

Authors:  Shaopeng Yuan; Martin Hollinger; Marrah E Lachowicz-Scroggins; Sheena C Kerr; Eleanor M Dunican; Brian M Daniel; Sudakshina Ghosh; Serpel C Erzurum; Belinda Willard; Stanley L Hazen; Xiaozhu Huang; Stephen D Carrington; Stefan Oscarson; John V Fahy
Journal:  Sci Transl Med       Date:  2015-02-25       Impact factor: 17.956

5.  Interleukin-13: central mediator of allergic asthma.

Authors:  M Wills-Karp; J Luyimbazi; X Xu; B Schofield; T Y Neben; C L Karp; D D Donaldson
Journal:  Science       Date:  1998-12-18       Impact factor: 47.728

6.  Requirement for IL-13 independently of IL-4 in experimental asthma.

Authors:  G Grünig; M Warnock; A E Wakil; R Venkayya; F Brombacher; D M Rennick; D Sheppard; M Mohrs; D D Donaldson; R M Locksley; D B Corry
Journal:  Science       Date:  1998-12-18       Impact factor: 47.728

7.  Interleukin-13-induced MUC5AC is regulated by 15-lipoxygenase 1 pathway in human bronchial epithelial cells.

Authors:  Jinming Zhao; Ben Maskrey; Silvana Balzar; Kazuyuki Chibana; Anthony Mustovich; Haizhen Hu; John B Trudeau; Valerie O'Donnell; Sally E Wenzel
Journal:  Am J Respir Crit Care Med       Date:  2009-02-12       Impact factor: 21.405

8.  Mechanosensitive ATP release maintains proper mucus hydration of airways.

Authors:  Brian Button; Seiko F Okada; Charles Brandon Frederick; William R Thelin; Richard C Boucher
Journal:  Sci Signal       Date:  2013-06-11       Impact factor: 8.192

9.  Pseudomonas infection and mucociliary and absorptive clearance in the cystic fibrosis lung.

Authors:  Landon W Locke; Michael M Myerburg; Daniel J Weiner; Matthew R Markovetz; Robert S Parker; Ashok Muthukrishnan; Lawrence Weber; Michael R Czachowski; Ryan T Lacy; Joseph M Pilewski; Timothy E Corcoran
Journal:  Eur Respir J       Date:  2016-03-23       Impact factor: 16.671

10.  ATP12A promotes mucus dysfunction during Type 2 airway inflammation.

Authors:  Alison T Lennox; Stefanie L Coburn; John A Leech; Elisa M Heidrich; Thomas R Kleyman; Sally E Wenzel; Joseph M Pilewski; Timothy E Corcoran; Mike M Myerburg
Journal:  Sci Rep       Date:  2018-02-01       Impact factor: 4.379

View more
  2 in total

1.  PTPRH Alleviates Airway Obstruction and Th2 Inflammation in Asthma as a Protective Factor.

Authors:  Feng-Jia Chen; Li-Juan Du; Zhimin Zeng; Xin-Yan Huang; Chang-Yi Xu; Wei-Ping Tan; Can-Mao Xie; Yu-Xia Liang; Yu-Biao Guo
Journal:  J Asthma Allergy       Date:  2022-02-02

2.  SARS-CoV-2 infection of airway cells causes intense viral and cell shedding, two spreading mechanisms affected by IL-13.

Authors:  Cameron B Morrison; Caitlin E Edwards; Kendall M Shaffer; Kenza C Araba; Jason A Wykoff; Danielle R Williams; Takanori Asakura; Hong Dang; Lisa C Morton; Rodney C Gilmore; Wanda K O'Neal; Richard C Boucher; Ralph S Baric; Camille Ehre
Journal:  Proc Natl Acad Sci U S A       Date:  2022-03-30       Impact factor: 12.779

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.